What are Mission Vision & Core Values of JCR Pharmaceuticals Company?

JCR Pharmaceuticals prioritizes patients suffering from various diseases, especially rare and genetic conditions. Their mission statement clearly reflects this focus, emphasizing the improvement of health and quality of life for those in need. This patient-centric approach guides their research and development efforts.

The market scope for JCR Pharma is global, with the aim of improving health worldwide. Their expansion into the U.S., Europe, and Latin America demonstrates their commitment to reaching patients across different regions. This global presence is crucial for fulfilling their mission.

Innovation is a key component of JCR Pharmaceuticals' mission. They leverage advanced biotechnologies and proprietary platforms, such as J-Brain Cargo®, to develop groundbreaking therapies. This commitment to innovation is essential for addressing unmet medical needs.

JCR Pharmaceuticals' mission is reflected in their specific product developments. The approval of IZCARGO® (pabinafusp alfa) in Japan for Hunter syndrome highlights their dedication to treating rare diseases. The ongoing development of JR-142 for pediatric growth hormone deficiency also aligns with their mission.

Collaborative research, such as the partnership with Modalis Therapeutics for novel gene therapy, underscores JCR Pharma's commitment to expanding treatment possibilities. These collaborations accelerate medical progress and contribute to their mission of improving patient outcomes globally. The company is investing significantly in R&D; in 2023, R&D expenses were approximately ¥10.5 billion, reflecting a commitment to innovation.

JCR Pharmaceuticals' strategic objectives are closely tied to its mission. These include expanding its product pipeline, increasing its global presence, and fostering strategic partnerships. These objectives are designed to ensure that JCR Pharma achieves its long-term vision of improving patient health worldwide. The company aims to launch several new products in the next five years, which will further solidify its position in the pharmaceutical market.

JCR Pharmaceuticals aspires to be a leader in the pharmaceutical industry. This aspiration is reflected in their commitment to developing groundbreaking medications.

The vision extends beyond immediate financial goals, aiming to improve health and wellness globally. This global perspective underscores JCR Pharma's commitment to making a worldwide impact.

Innovation is at the core of JCR Pharmaceuticals' vision. Their proprietary J-Brain Cargo® technology exemplifies their dedication to cutting-edge research and development.

JCR Pharmaceuticals prioritizes areas with significant unmet needs, such as rare diseases and regenerative medicine. This strategic focus allows them to address critical healthcare gaps.

Despite the ambitious nature of their vision, JCR Pharmaceuticals' trajectory suggests a realistic approach. With a 50-year legacy and ongoing global expansion, they are building a solid foundation.

The company's financial strategy is crucial for realizing its vision. With a forecast of JPY37,800 million in sales and JPY3,000 million in net income for the fiscal year ending March 31, 2026, JCR Pharma is focused on improving its financial standing.

JCR Pharma strategically expands its global presence to align with its mission of improving health worldwide and its vision of becoming a global leader. This expansion is a key strategic objective, driven by the company's core values.

Collaborations are carefully selected to support JCR Pharmaceuticals' mission and vision, accelerating medical advancements and exploring new therapeutic solutions. These partnerships are crucial for achieving its strategic objectives.

JCR Pharmaceuticals integrates environmental considerations into its business activities, demonstrating a commitment to creating long-term value and contributing to a sustainable society. This aligns with their overarching corporate philosophy and company values.

Leadership at JCR Pharmaceuticals actively reinforces the mission and vision, influencing resource allocation, R&D focus, and patient-centric approaches. This ensures that the core beliefs are consistently applied.

The company's philosophy of "Think by oneself, act by oneself" fosters a culture of innovation and responsibility, permeating daily activities. This promotes a dynamic environment within JCR Pharmaceuticals.

JCR Pharma's commitment to patients is reflected in its focus on addressing unmet medical needs and developing innovative treatments. This patient-centric approach is central to their mission.

Leadership plays a pivotal role in reinforcing JCR Pharma’s mission, vision, and core values. Shin Ashida, Chairman, President, and CEO, consistently communicates the company's commitment to advancing science and addressing unmet medical needs, fostering a culture aligned with its core beliefs.

JCR Pharmaceuticals actively communicates its mission and vision to all stakeholders through various channels, including its revamped global website launched in June 2025. This website is tailored for a global audience, reflecting the company's passion for science and humanity.

JCR Pharma integrates sustainability into its business practices, as demonstrated by its Midterm Business Plan for FY2023-2027, 'Reach Beyond, Together'. This plan focuses on rare diseases, environment, society, and corporate governance, reflecting the company's commitment to long-term sustainability. The company is committed to establishing a production system that ensures a stable supply of high-quality pharmaceuticals with environmental considerations.

While specific formal programs are not explicitly detailed, JCR Pharmaceuticals' "Basic Business Policies," derived from its core values, indicate structured approaches to uphold its principles. These policies, such as "Management with Focus on Customer Satisfaction" and "Management Following Laws and Internal Rules based on Social Commonsense," provide a framework for operationalizing its core values.